Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
69°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about obesity
Recent news which mentions obesity
Novo Nordisk Surges Nearly 3% After Weight Loss Drug Wegovy Wins Approval in China
June 25, 2024
Tickers
NEWS
NVO
Tags
obesity
China
Benzinga
From
Benzinga
Introducing AllyMack: The All-Natural Alternative to Ozempic®
June 10, 2024
Tags
California
Semaglutide
THCV
From
PRLog
Chinese Generic Ozempic, Wegovy Versions Could Put Novo Nordisk At The Risk Of Stiff Competition In Key Market
June 05, 2024
Tickers
LLY
NEWS
NVO
Tags
obesity
weight loss drugs
Benzinga
From
Benzinga
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Weight management
Business
Obesity
From
CNBC.com News
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
May 29, 2024
Tickers
HRTS
LLY
NEWS
NVO
Tags
obesity
Benzinga
HRTS
From
Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
Tickers
BHVN
GPCR
LLY
NEWS
Tags
Biotech
Benzinga
obesity
From
Benzinga
Friday File: NVIDIA by the Fingernails, Gold (and other shiny things), Energy Storage and more…
March 22, 2024
Tickers
GOLD
Tags
Market Vectors Gold Miners ETF (GDX)
Royal Gold (RGLD)
Royal Philips (PHG)
From
Stock Gumshoe
Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
March 19, 2024
Tickers
NEWS
NVO
Tags
Markets
Market News
News
From
Benzinga
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
March 14, 2024
Tags
Health care industry
Eli Lilly and Co
CNBC Changemakers
From
CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
March 13, 2024
Tags
Markets
Investment strategy
Novo Nordisk A/S
From
CNBC.com News
US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
March 12, 2024
Tickers
NEWS
NVO
SYRA
Tags
Market News
Health Care
NVO
From
Benzinga
Ozempic Maker Novo Nordisk To Introduce Obesity Drug Wegovy In Japan, Acknowledging Country's Rising Weight Issue
March 07, 2024
Tickers
ASIA
NEWS
NVO
Tags
Asia
weight/loss drug
Benzinga
From
Benzinga
WeightWatchers Stock Falls After Q4 Results, Oprah Winfrey Exits
February 28, 2024
Tickers
NEWS
WW
Tags
Market News
WW
Oprah Winfrey
From
Benzinga
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
WW Grainger Inc
Medifast Inc
CNBC Changemakers
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Novo Nordisk A/S
Labor economy
Personnel
From
CNBC.com News
Nvidia rally is fueling FOMO in the overall market, Evercore's Julian Emanuel warns
February 12, 2024
Tags
High/yield bonds
Investing
Internet technology
From
CNBC.com News
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
December 04, 2023
Tickers
ALT
HRTS
LLY
NVO
Tags
Benzinga
ETFs
PFE
From
Benzinga
Hernias, COVID, Obesity Drugs and Medicare Negotiation
November 15, 2023
Tags
surgery
Doc Gumshoe
Novo Nordisk (NVO)
From
Stock Gumshoe
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Breaking News: Markets
Stock markets
Health insurance
From
CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Eli Lilly and Co
Health care industry
Diabetes
From
CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
September 09, 2023
Tags
Amgen Inc
Drugs
Health & Science
From
CNBC.com News
Your boarding pass and weight, please: Why airlines are asking passengers to step on the scales
August 27, 2023
Tickers
LIFE
Tags
Hospitality and leisure industry
Air New Zealand Ltd
CNBC Travel
From
CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
August 10, 2023
Tags
Deals & IPOs
Breaking news
Weight management
From
CNBC.com News
Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance
August 10, 2023
Tickers
LLY
NVO
Tags
Ozempic
wegovy
Equities
From
Benzinga
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
August 09, 2023
Tags
Weight loss surgery
Medicare health plans
CVS Health Corp
From
CNBC.com News
Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%
August 08, 2023
Tags
Drug trials
Earnings
Health care industry
From
CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
Tags
Health care industry
Eli Lilly and Co
Clinical trials
From
CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
July 26, 2023
Tags
Health & Science
Business News
Companies
From
CNBC.com News
Ozempic Alternatives: These Two Drugs Show Promise In Affordability And Effectiveness For Weight Loss
July 24, 2023
Tags
Orforglipron
Retatrutide
obesity
From
Benzinga
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
July 14, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Medication
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.